138 related articles for article (PubMed ID: 31948091)
1. CD276-Positive Circulating Endothelial Cells Do Not Predict Response to Systemic Therapy in Advanced Colorectal Cancer.
Gootjes EC; Kraan J; Buffart TE; Bakkerus L; Zonderhuis BM; Verhoef C; Verheul HMW; Sleijfer AS
Cells; 2020 Jan; 9(1):. PubMed ID: 31948091
[TBL] [Abstract][Full Text] [Related]
2. Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells.
Kraan J; van den Broek P; Verhoef C; Grunhagen DJ; Taal W; Gratama JW; Sleijfer S
Br J Cancer; 2014 Jul; 111(1):149-56. PubMed ID: 24892449
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.
Malka D; Boige V; Jacques N; Vimond N; Adenis A; Boucher E; Pierga JY; Conroy T; Chauffert B; François E; Guichard P; Galais MP; Cvitkovic F; Ducreux M; Farace F
Ann Oncol; 2012 Apr; 23(4):919-27. PubMed ID: 21825101
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer.
Matsusaka S; Suenaga M; Mishima Y; Takagi K; Terui Y; Mizunuma N; Hatake K
Cancer Chemother Pharmacol; 2011 Sep; 68(3):763-8. PubMed ID: 21170650
[TBL] [Abstract][Full Text] [Related]
5. Predictive and prognostic significance of circulating endothelial cells in advanced non-small cell lung cancer patients.
Yuan DM; Zhang Q; Lv YL; Ma XQ; Zhang Y; Liu HB; Song Y
Tumour Biol; 2015 Nov; 36(11):9031-7. PubMed ID: 26084612
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of circulating endothelial cells in metastatic colorectal cancer.
Rahbari NN; Schölch S; Bork U; Kahlert C; Schneider M; Rahbari M; Büchler MW; Weitz J; Reissfelder C
Oncotarget; 2017 Jun; 8(23):37491-37501. PubMed ID: 28415583
[TBL] [Abstract][Full Text] [Related]
7. Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients.
Ali AM; Ueno T; Tanaka S; Takada M; Ishiguro H; Abdellah AZ; Toi M
Eur J Cancer; 2011 Oct; 47(15):2265-72. PubMed ID: 21737256
[TBL] [Abstract][Full Text] [Related]
8. Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer.
Manzoni M; Mariucci S; Delfanti S; Rovati B; Ronzoni M; Loupakis F; Brugnatelli S; Tinelli C; Villa E; Falcone A; Danova M
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1187-96. PubMed ID: 22419441
[TBL] [Abstract][Full Text] [Related]
9. Circulating endothelial progenitors and CXCR4-positive circulating endothelial cells are predictive markers for bevacizumab.
Matsusaka S; Mishima Y; Suenaga M; Terui Y; Kuniyoshi R; Mizunuma N; Hatake K
Cancer; 2011 Sep; 117(17):4026-32. PubMed ID: 21858803
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SOGUG-CEC-2011-01).
García-Donas J; Leon LA; Esteban E; Vidal-Mendez MJ; Arranz JA; Garcia Del Muro X; Basterretxea L; González Del Alba A; Climent MA; Virizuela JA; Álvarez C; Sepúlveda J; Anido U; López C; Ortiz-Morales MJ; Pérez X; Rodriguez-Antona C; Rodriguez-Moreno JF; Hernando S; Castellano D
Eur Urol Focus; 2017 Oct; 3(4-5):430-436. PubMed ID: 28753791
[TBL] [Abstract][Full Text] [Related]
11. Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy.
Starlinger P; Brugger P; Reiter C; Schauer D; Sommerfeldt S; Tamandl D; Kuehrer I; Schoppmann SF; Gnant M; Brostjan C
Neoplasia; 2011 Oct; 13(10):980-90. PubMed ID: 22028623
[TBL] [Abstract][Full Text] [Related]
12. Circulating endothelial cell (CEC) as a diagnostic and prognostic marker in malignant pleural mesothelioma (MPM).
Yoneda K; Tanaka F; Kondo N; Orui H; Hashimoto M; Takuwa T; Matsumoto S; Okumura Y; Tsubota N; Sato A; Tsujimura T; Kuribayashi K; Fukuoka K; Nakano T; Hasegawa S
Ann Surg Oncol; 2012 Dec; 19(13):4229-37. PubMed ID: 22825770
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET).
Vasseur A; Cabel L; Tredan O; Chevrier M; Dubot C; Lorgis V; Jacot W; Goncalves A; Debled M; Levy C; Ferrero JM; Jouannaud C; Luporsi E; Mouret-Reynier MA; Dalenc F; Lemonnier J; Savignoni A; Tanguy ML; Bidard FC; Pierga JY
Angiogenesis; 2020 May; 23(2):193-202. PubMed ID: 31773439
[TBL] [Abstract][Full Text] [Related]
15. Circulating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.
DuBois SG; Stempak D; Wu B; Mokhtari RB; Nayar R; Janeway KA; Goldsby R; Grier HE; Baruchel S
Pediatr Blood Cancer; 2012 Feb; 58(2):181-4. PubMed ID: 21319292
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of Circulating Endothelial Cells by CD34 Microbeads Followed by Enumeration Using Flow Cytometry.
Burylo AM; de Weger VA; Stuurman FE; Beijnen JH; Schellens JHM
Thromb Haemost; 2017 Dec; 117(12):2356-2368. PubMed ID: 29212123
[TBL] [Abstract][Full Text] [Related]
17. Increased pre-surgical numbers of endothelial progenitor cells and circulating endothelial cells in colorectal cancer fail to predict outcome.
Ramcharan KS; Lip GY; Stonelake PS; Blann AD
Int J Colorectal Dis; 2015 Mar; 30(3):315-21. PubMed ID: 25598043
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients.
Ronzoni M; Manzoni M; Mariucci S; Loupakis F; Brugnatelli S; Bencardino K; Rovati B; Tinelli C; Falcone A; Villa E; Danova M
Ann Oncol; 2010 Dec; 21(12):2382-2389. PubMed ID: 20497963
[TBL] [Abstract][Full Text] [Related]
19. On the origin of (CD105+) circulating endothelial cells.
Strijbos MH; Verhoef C; Gratama JW; Sleijfer S
Thromb Haemost; 2009 Aug; 102(2):347-51. PubMed ID: 19652886
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer.
Wang ZS; Zhong M; Bian YH; Mu YF; Qin SL; Yu MH; Qin J
Oncotarget; 2016 Jul; 7(28):44266-44276. PubMed ID: 27329595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
